Skip to main content
. 2012 Oct 18;16(5):R198. doi: 10.1186/cc11686

Figure 8.

Figure 8

Mortality and unfavorable outcome according to clazosentan dose. Subgroup analysis for mortality and unfavorable outcome at the end of follow-up according to the dose of clazosentan. CI, confidence interval; df, degrees of freedom M-H, Mantel-Haenszel.